PharmaOnco™ CD22 CHO Recombinant Cell Line (Medium Expression) (Human)

Useful for screening and validating antibodies against CD22 and different CD22 CAR-T for immunotherapy research and drug discovery. Also useful for CD22 binding assays to screen for CD22 ligands.

Human

2 vials

-80C

Store in liquid nitrogen immediately upon receipt.